Study: Hormonal Birth Control Does Not Increase Risk of Breast Cancer

Print icon

When it comes to a connection between hormone contraceptives and breast cancer, there seems little for women to worry about, according to a recent study.

Dr. Sapna Khubchandani, an oncologist and breast health specialist with Hartford HealthCare Medical Group Oncology and Hematology in Waterford, says the study published in the New England Journal of Medicine shows the connection to be minimal.

“About 140 million women worldwide use hormonal contraception,” she says, “but there is very little data associating it with breast cancer, especially the newer hormonal contraceptives containing low-dose estrogen and progesterone.”

While previous studies of women on a combination of estrogen and progesterone offered inconsistent results — increases in breast cancer risk ranged from none to about 30 percent — Khubchandani says there has been hardly any data on the same risk related to the use of pills containing just progesterone or non-oral contraception like vaginal rings, IUDs or implants using only progesterone.

The article in the New England Journal of Medicine focused on a prospective cohort study in which 1.8 million women ages 15-49 taking hormonal contraception were followed for about 10 years. As compared to women who had never taken hormonal contraceptives, the relative risk of breast cancer among women in the study increased just 1.20 times with the medication.

The risk of breast cancer did increase the longer a woman took the hormonal contraception – from a relative risk increase of 1.09 in the first year of use to 1.38 after more than 10 years of use. Among the women who used hormonal contraception for more than five years, the risk remained high for atleast five years after stopping the drug.

“We believe that it is still safe for women to take oral contraceptives with low-dose estrogen and progesterone as it seems to minimally increase their risk of developing breast cancer,” says Khubchandani.

Click here for more information on Hartford HealthCare Medical Group Oncology and Hematology in Waterford.

 


What's New


The Orchards at Southington receives Activate Southington grant

LeaAnn Blanchard, director of social services at The Orchards at Southington, third from left, gathers with members of Activate Southington and other grant recipients outside the Southington YMCA Women’s Health & Wellness Center. Blanchard’s program, “Laughter with LeaAnn,” received funding to support its expansion to several days each week. The...


DAWN Protocols are Revolutionizing Stroke Treatment and Care

DAWN is a groundbreaking study that is changing the way doctors are treating people who have had strokes. Dr. Mark Alberts is the physician-in-chief at the Hartford HealthCare Ayer Neuroscience Institute with details. Q.  What do these protocols mean for stroke patients?  A.  This new study (called the DAWN Trial...


A Grill Brush, A Burger . . . And Emergency Surgery

Cleaning your grill with a wire brush can be dangerous, as one Wallingford woman learned in 2015. Cheryl Harrison was rushed to MidState Medical Center in Meriden in extreme stomach pain two days after eating a hamburger containing a wire bristle from a barbecue grill brush. A CT scan revealed...


Photo Gallery: Hartford HealthCare Dancing for Parkinson’s Event

The Hartford HealthCare Ayer Neuroscience Institute hosted the inaugural Hartford HealthCare’s Dancing for Parkinson’s fundraising event May 11 at the Hartford Hilton Hotel.  The evening will included a dance competition featuring special guests and judges from Hartford HealthCare and the state and music by the De Novo Band. Proceeds benefit...

Closeup of man tying sneaker.

A Closer Look at Longtime Runner’s Knee-Replacement Surgery

When Richard Kristoff was about 40 years old, his brother called him fat, launching a 45-year passion for running. The Columbia native ran at least five miles a day, more on weekends, in pockets of time he found around his work schedule with Pratt & Whitney, where he spent 40...


Keeping an Eye on Ocular Melanoma

Malignant melanoma of the eye – ocular melanoma – is rare. But there are common precursors of the disease. Dr. Scott Walter from the Hartford HealthCare Cancer Institute’s Melanoma and Skin Cancer Center is one of only two ocular oncologists practicing in Connecticut.   Q: What is ocular melanoma? A: Ocular...